# TetraSOD® Supplementation and Skeletal Muscle Redox Gene Expression

> **NCT06822556** · NA · COMPLETED · sponsor: **Loughborough University** · enrollment: 15 (actual)

## Conditions studied

- Placebo
- Tetraselmis Chuii

## Interventions

- **DIETARY_SUPPLEMENT:** Placebo
- **DIETARY_SUPPLEMENT:** Tetraselmis chuii

## Key facts

- **NCT ID:** NCT06822556
- **Lead sponsor:** Loughborough University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-05
- **Primary completion:** 2022-08-03
- **Final completion:** 2023-10-30
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06822556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06822556, "TetraSOD® Supplementation and Skeletal Muscle Redox Gene Expression". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06822556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*